Table 4. Types of DRPs identified as potential causes of ineffectiveness or unsafety of uncontrolled health problems’ treatment.
| Month 1 (n=688) | Month 2 (n=669) | Month 3 (n=662) | Month 4 (n=661) | Month 5 (n=654) | Month 6 (n=646) | |
|---|---|---|---|---|---|---|
| Total number of uncontrolled health problems with a DRP | 349 (65.1%) | 391 (83.0%) | 274 (78.1%) | 213 (74.7%) | 197 (73.5%) | 105 (58.7%) |
| Wrong administration | 21 (6%) | 13 (3.3%) | 10 (3.6%) | 6 (2.8%) | 3 (1.5%) | 1 (1.0%) |
| Individual characteristics | 28 (8%) | 44 (11.3%) | 30 (10.9%) | 24 (11.3%) | 27 (13.7%) | 12 (11.4%) |
| Contraindication | 2 (0.6%) | 6 (1.5%) | 5 (1.8%) | 1 (0.5%) | 1 (0.5%) | - |
| Wrong dose/ posology/lenght | 40 (11.5%) | 46 (11.8%) | 29 (10.6%) | 22 (10.3%) | 17 (10.6%) | 15 (14.3%) |
| Duplicity | 8 (2.3%) | 8 (2.0%) | 4 (1.5%) | 3 (1.4%) | 3(1.5%) | 2 (1.9%) |
| Wrong prescription | 9 (2.6%) | 9 (2.3%) | 5 (1.8 %) | 3 (1.4%) | 4 (2.0%) | 1 (1.0%) |
| Non-adherence | 77 (22.1%) | 67 (17.1%) | 37 (13.5%) | 32 (15.0%) | 29 (14.7%) | 19 (18.1%) |
| Interactions | 9 (2.6%) | 9 (2.3%) | 8 (2.9%) | 3 (1.4%) | 3 (1.5%) | 1 (1.0%) |
| Not necessary drug | 5 (1.4%) | 3 (0.8%) | 3 (1.1%) | 1 (0.5%) | 2 (1.0%) | 2 (1.9%) |
| Other conditions that affect the treatment | 6 (1.7%) | 11 (2.8%) | 6 (2.2%) | 4 (1.9%) | 4 (2.0%) | 4 (3.8%) |
| Risk of adverse effects | 45 (12.9%) | 57 (14.6%) | 34 (12.4%) | 27 (12.7%) | 30 (15.2%) | 14 (13.3%) |
| Undertreated condition | 102 (29.2%) | 130 (33.2%) | 106 (38.7%) | 94 (44.1%) | 86 (43.7%) | 41 (39.0%) |
| Other DRPs | 13 (3.7%) | 10 (2.6%) | 11 (4.0%) | 9 (4.2%) | 6 (3.0%) | 3 (2.9%) |
DRP: drug related problem